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Abstract
Topoisomerase II (Top2) is a nuclear enzyme involved in several metabolic processes of DNA. Chemotherapy agents that
poison Top2 are known to induce persistent protein-mediated DNA double strand breaks (DSB). In this report, by using
knock down experiments, we demonstrated that Top2a was largely responsible for the induction of cH2AX and cytotoxicity
by the Top2 poisons idarubicin and etoposide in normal human cells. As DSB resulting from Top2 poisons-mediated
damage may be repaired by non-homologous end joining (NHEJ) or homologous recombination (HR), we aimed to analyze
both DNA repair pathways. We found that DNA-PKcs was rapidly activated in human cells, as evidenced by
autophosphorylation at serine 2056, following Top2-mediated DNA damage. The chemical inhibition of DNA-PKcs by
wortmannin and vanillin resulted in an increased accumulation of DNA DSB, as evaluated by the comet assay. This was
supported by a hypersensitive phenotype to Top2 poisons of Ku80- and DNA-PKcs- defective Chinese hamster cell lines. We
also showed that Rad51 protein levels, Rad51 foci formation and sister chromatid exchanges were increased in human cells
following Top2-mediated DNA damage. In support, BRCA2- and Rad51C- defective Chinese hamster cells displayed
hypersensitivity to Top2 poisons. The analysis by immunofluorescence of the DNA DSB repair response in synchronized
human cell cultures revealed activation of DNA-PKcs throughout the cell cycle and Rad51 foci formation in S and late S/G2
cells. Additionally, we found an increase of DNA-PKcs-mediated residual repair events, but not Rad51 residual foci, into
micronucleated and apoptotic cells. Therefore, we conclude that in human cells both NHEJ and HR are required, with cell
cycle stage specificity, for the repair of Top2-mediated reversible DNA damage. Moreover, NHEJ-mediated residual repair
events are more frequently associated to irreversibly damaged cells.
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Introduction
DNA double strand breaks (DSB) are dangerous lesions
threatening the genome stability. DSB are induced from many
sources, including oxidative stress, ionizing radiation and chemical
compounds [1]. Under non physiological conditions, certain
nuclear enzymes, such as Topoisomerase II (Top2), may also
generate persistent protein-mediated DNA DSB [2].
Top2 is a ubiquitous enzyme that solves topological problems of
the DNA during replication, transcription and chromosome
condensation [3,4]. Top2 catalyzes the interconvertion of
topological isomers of DNA through a transient DSB, while
remains covalently linked to the 59 terminus of the DNA, and is
followed by double-strand passing and religation [5]. In mamma-
lian cells, there are two isoforms of Top2, a and b, which show
similar structural features and catalytic activities [6]. In spite of
their similarities, they play different roles in nuclear processes,
being Top2a mainly implicated in DNA relaxation/decatenation
and segregation [7] and Top2b mostly associated to transcription
[8,9]. Furthermore, the expression of both isoforms is differently
regulated, with Top2a levels rising from S phase to M [10,11] and
Top2b remaining constant throughout the cell cycle [12].
Top2 is the main target of several clinically relevant anticancer
drugs, such as idarubicin (IDA) and etoposide (ETO) [13,14].
These agents poison Top2 by stabilizing DNA-Top2 complexes,
referred to as cleavable complexes, preventing the religation of the
broken ends. Stabilized cleavable complexes are reversible upon
drug removal [15]; however, their persistence leads to DSB
formation.
In mammals, at least two main DSB repair pathways have
evolved, namely non-homologous end joining (NHEJ) and
homologous recombination (HR). NHEJ operates by modifying
and religating the broken ends regardless of sequence homology;
and thus, being potentially mutagenic [16]. NHEJ is controlled by
the DNA-PK complex, composed by the DNA-end binding
Ku70/Ku80 heterodimer, and the catalytic subunit DNA-PKcs.
Additional factors implicated in this pathway include Artemis,
Ligase IV, XRCC4 and XLF/Cernunnos [17–19]. The activation
of DNA-PKcs upon DNA damage involves several autopho-
sphorylation events at serine/threonine residues in two clusterized
sites; one of them includes serine 2056 (pS2056DNA-PKcs) [20–
22]. The autophosphorylation of DNA-PKcs is thought to regulate
the kinase activity of the enzyme, as well as the accessibility of
other NHEJ components to the DNA ends [23].
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homologous sequence is used as a template to direct the repair
process [24]. The HR pathway is mediated by the MRN complex
(Mre11/Rad50/Nbs1), RPA, Rad51, Rad52, Rad54, Rad54B,
Rad51 paralogs (Rad51B, Rad51C, Rad51D, XRCC2, XRCC3),
BRCA1 and BRCA2 [25–27]. After an initial end processing by
the MRN complex, RPA molecules stabilize the single-stranded
DNA stretches. RPA is then replaced by Rad51 to promote the
invasion to a homologous template for priming the DNA synthesis
[28].
Although Top2 poisons are widely used anticancer drugs, they
are often associated to the development of secondary malignan-
cies, particularly therapy-related acute myeloid leukemia (t-AML)
[29]. In addition, experimental evidence on knockout mice
suggested a tight dependence on Top2b isoform for DSB
formation and skin carcinogenesis in response to Top2 poisons
[30].
Taking into account the side effects of Top2 poisons, a
particular interest has emerged in understanding the repair
mechanisms involved in the restoration of Top2-mediated DNA
DSB. In this regard, several authors have highlighted the
important role of NHEJ in the survival to Top2 poison-induced
damage [31–33]. On the other hand, HR has been suggested to be
functional on Top2 poisons-induced irreversibly DNA damaged
cells [32]. It is probable that both DSB repair activities are
differently required after either Top2-mediated reversible or
irreversible DNA damage, but it still needs to be clarified.
Here we present evidence for an important role of Top2a in the
induction of DNA damage by Top2 poisons. In addition, we
provide a systematic analysis of the DNA DSB repair activities
resulting from Top2-mediated DNA damage in mammalian cells.
Results
Top2 poisons induce DSB and cytotoxicity in a Top2a-
dependent manner
In order to determine the involvement of Top2a in the DNA
DSB formation induced by Top2 poisons, we performed knock-
down experiments in human fibroblasts with a specific morpholino
oligonucleotide targeting Top2a (MO-Top2a) or a standard
control (MO-SC). As shown in Fig. 1A, the MO-Top2a caused
a substantial downregulation of Top2a at 48 h, but not of Top2b,
Tdp1 and actin. This result was confirmed by immunofluores-
cence analysis, which showed a significant decrease (p=0.0001) in
the number of Top2a positive nuclei at 48 h (Fig. 1B). The
proliferation rates after transfection with MO-Top2a were not
disturbed during the time course of the experiments (data not
shown).
Human fibroblasts transfected with MO-Top2a or MO-SC
were treated with 0.01 mg/ml IDA or 10 mg/ml ETO during 2 h,
and analyzed for the induction of cH2AX foci (Fig. 1C). This assay
revealed that in absence of Top2a, both IDA and ETO induce
cH2AX recognizable foci in a small amount of cells (p=0.0007
and p=0.0076, respectively).
To elucidate the role of Top2a in the cytotoxicity induced by
Top2 poisons, MO-Top2a and MO-SC transfected cells were
treated with increasing doses of IDA or ETO and the cell death
was determined after 36 h by the trypan blue assay. As shown in
Figs. 1D and 1E, increased doses of either drug resulted into an
enhanced cell death in MO-SC transfected cells for up to 6.7- and
4.9-fold of control in IDA and ETO treatments, respectively. In
contrast, cell death levels increased only up to 1.5- and 1.4-folds
respect to controls in MO-Top2a transfected cells, at the highest
dose assayed. Concordant results were obtained with the MTT
assay. IDA and ETO decreased the metabolic activity of MO-SC
transfected cells for up to 65.4%61.4 (p=0.0034) and 67.5%68.2
(p=0.0008), whereas MO-Top2a transfectants remained with a
92%611.3 and 97.7%65.1 of activity, respectively. We conclude,
therefore, that Top2a is required for the induction of cH2AX and
cytotoxicity after treatment with Top2 poisons in normal human
cells.
Kinetics of DNA DSB repair induced by Top2 poisons
To characterize the kinetics of DSB formation and repair,
human fibroblast cultures were treated with 0.01 mg/ml IDA or
10 mg/ml ETO for 2 h, and analyzed at different times by the
neutral comet assay. As shown in Figs. 2A and 2B, IDA and ETO
induced different kinetics of DSB formation, with maximal values
at 6 h and 2 h, respectively. They also showed a slow kinetics of
repair, with DSB levels remaining above control after 26 h. The
evaluation of cH2AX foci formation confirmed these results
(Figs. 2C and 2D). The analysis of cH2AX by flow cytometry
indicated that both drugs induced DSB in all the stages of the cell
cycle (Fig. 2E). The Annexin V analysis (Fig. 2F) for up to 72 h
post-treatment showed that DSB induced at doses used in the
kinetics study are mostly repairable lesions that do not induce
increased cell death.
NHEJ is involved in the repair of Top2 poison induced
DSB
To elucidate the participation of NHEJ in the repair of DSB
induced by Top2 poisons we evaluated the induction of
pS2056DNA-PKcs foci at different times after treatment with
IDA or ETO. Fig. 3A shows that both drugs stimulated a rapid
accumulation of pS2056DNA-PKcs, with the highest response in
accordance with the time of maximal induction of damage. Both
treatments showed a small amount of cells with persistent
pS2056DNA-PKcs nuclear immunostaining at 26 h.
In order to determine whether the lack of functional NHEJ
results into DSB accumulation, we pretreated the human
fibroblasts with the DNA-PKcs chemical inhibitors WTM and
VN. The doses of WTM and VN assayed diminished the
activation induced by ETO of DNA-PKcs by a 49.6% and
58.4%, respectively; with no significant effect on ATM (data not
shown).
As shown in Figs. 3B and 3D, both pretreatments did not
increase substantially the damage induced by IDA and ETO; but
later times resulted into higher levels of damage. Figs. 3C and 3E
represent the percentage of damage in pretreated cultures relative
to treatment with IDA or ETO alone. After 26 h, VN- and WTM-
pretreatments resulted into an accumulation of about 30–50% and
50–60% of damage respect to IDA and ETO alone, respectively.
To further probe the involvement of NHEJ in the repair of DSB
induced by Top2 poisons, mutant Chinese hamster cell lines were
analyzed by the colony formation assay. The experiments showed
that XR-C1 (DNA-PKcs mutant) and XR-V15B (Ku80 mutant)
cells were hypersensitive to both IDA and ETO (Figs. 3F and 3G).
Together, these data demonstrate the important role of NHEJ in
the repair of Top2-mediated DNA damage in mammalian cells.
HR participates in the repair of DSB induced by Top2
poisons
In order to study the involvement of the HR pathway in the
repair of DSB resulting from Top2 poisoning we evaluated the
induction of Rad51 foci at different times after treatment with
both IDA and ETO in human fibroblasts. Nuclei containing $10
foci were scored as positive. Figs. 4A and 4B show that IDA and
Repair of Top2-Induced Damage
PLoS ONE | www.plosone.org 2 September 2010 | Volume 5 | Issue 9 | e12541ETO induced Rad51 foci formation with values that picked up to
6 and 2 h, respectively. Later times resulted into a decreasing
number of cells containing Rad51 foci. The analysis of Rad51
protein levels showed similar results (Figs. 4C and 4D). Both drugs
enhanced the expression of Rad51 with the highest levels found at
times of maximal induction of DNA damage. The decreased levels
of Rad51 protein at later times were related to degradation by the
26S proteosome (data not shown).
The events of sister chromatid exchanges (SCE) are believed to
result from a Rad51-dependent HR pathway [34]. To test a
functional activity of a Rad51-mediated process in response to
Top2 poisons, we analyzed the induction of SCE after treatments
with IDA and ETO. Fig. 4E shows that both treatments resulted in
increased levels of SCE on human fibroblasts.
To further corroborate the participation of HR in the repair of
DSB induced by Top2 poisons, we performed colony formation
Figure 1. Top2a down regulation and induction of cH2AX and cytotoxicity by Top2 poisons. (A) Western blot and (B)
immunofluorescence analysis of Top2a following transfection with 1 mM of MO-Top2a or MO-SC at different times on human fibroblasts.
*p=0.0001 (vs. respective control). (C) At 48 h post-transfection, fibroblasts were treated with IDA (0.01 mg/ml) or ETO (10 mg/ml) for 2 h and
analyzed immediately (ETO) or after 4 h (IDA) for the induction of cH2AX by immunofluorescence. *p=0.0007 (vs. IDA-treated MO-SC); **p=0.0076
(vs. ETO-treated MO-SC). (D and E) MO-Top2a and MO-SC cells were treated with increasing doses of IDA (D) or ETO (E) for 2 h and analyzed at 36 h
by trypan blue exclusion and the MTT assay. * and #p,0.005 (vs. MO-Top2a). All comparisons were performed by the Student t-test.
doi:10.1371/journal.pone.0012541.g001
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PLoS ONE | www.plosone.org 3 September 2010 | Volume 5 | Issue 9 | e12541Figure 2. Kinetics of DNA DSB repair induced by Top2 poisons. The kinetics of DNA DSB repair induced by IDA (0.01 mg/ml) or ETO (10 mg/
ml) were determined by the neutral comet assay (A and B, respectively) and the resulting cH2AX foci formation confirmed by immunofluorescence (C
and D, respectively). Capped lines (A–D) represent the extension of the treatment. (E) Representative flow cytomtery analysis of the cH2AX signals
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CL-V4B (Rad51C mutant). The results showed that mutant cells
were hypersensitive to IDA and ETO, as compared to their
isogenic wild-type cell lines (Figs. 4F and 4G).
NHEJ and HR contribute with cell cycle phase specificity
to the repair of Top2 poison-induced damage
It has been suggested that DSB repair pathways may be
differentially regulated during the cell cycle, with a major activity
of NHEJ in G1/early S phase and HR playing a major role on late
S/G2 [35,36].
To determine the specific DSB repair activities induced by
Top2 poisons throughout the cell cycle, we performed immuno-
fluorescence analysis of pS2056DNA-PKcs and Rad51 on human
fibroblast synchronized cultures after treatments with IDA and
ETO. A schematic representation of the synchronization condi-
tions and treatments is depicted in Fig. 5A. Under these
conditions, S phase cells were scored by the presence of BrdU
labelling. In the same way, cells treated during late S/G2 were
recognized by their uniformly BrdU-labelled nuclei.
As shown in Fig. 5B, IDA and ETO treatments were able to
induce phosphorylation of DNA-PKcs at S2056 in cells at G0/G1
(p#0.009), S (p#0.001), and late S/G2 (p#0.006) phases of the
cell-cycle. Whereas the analysis of nuclei containing Rad51 foci
revealed that neither IDA nor ETO was able to induce Rad51 foci
formation in cells at G0/G1. However, there was a significant
induction of Rad51 foci during S phase (p#0.001), and late S/G2
(p#0.03) of the cell-cycle (Fig. 5C).
Persistent DNA damage induced by Top2 poisons results
in micronucleated and apoptotic cells containing
activated DNA-PKcs
Previous reports have demonstrated that Rad51 foci can be
found in micronuclei and apoptotic cells following treatment with
different genotoxic agents, including Top2 poisons [37,38]. Those
foci were proposed to result from HR-mediated failed repair
events [37]. So far, there is no evidence of residual NHEJ activities
associated to micronucleated and early apoptotic cells after a
genotoxic insult.
In order to determine whether NHEJ- or HR- residual foci are
present in persistently damaged cells, we performed immunoflu-
orescence analysis of pS2056DNA-PKcs and Rad51 on micro-
nucleated and apoptotic cells. As late apoptotic cells show a diffuse
staining pattern of activated DNA-PKcs at regions of poor DNA
content [39], we looked for Annexin-V labelled cells with
pS2056DNA-PKcs nuclear foci remaining on DNA. This staining
pattern is very different from that reported by Mukherjee et al.
[39]; and therefore, suggestive of residual repair events.
Human fibroblasts were treated for 2 h with increasing doses of
both IDA and ETO and analyzed 36 h later. The frequency of
cH2AX positive micronucleated cells ranged from 86 to 90% for
either treatment throughout the doses assayed (data not shown).
Figs. 6A and 6C show the frequency of micronucleated and
apoptotic cells containing Rad51 foci after increasing dose of IDA
and ETO, respectively. The frequency of micronucleated cells
containing Rad51 foci induced by IDA was low and represented
from 11.2% to 14.7% of the micronucleated population. Similarly,
the values obtained after treatment with ETO ranged from 8.2%
to 13.6%. Apoptotic cells containing Rad51 foci represented 10–
11% of the apoptotic population for all the increasing doses of
both IDA and ETO treatments.
The analysis of micronucleated cells containing pS2056DNA-
PKcs showed frequencies ranging from 11.6% to 27.8% after IDA
treatment (Fig. 6B), while 5% to 16.7% were found after ETO
treatment (Figs. 6D and 6E, top panel). The scoring of apoptotic
cells containing pS2056DNA-PKcs foci showed a higher increase,
with frequencies ranging from 40.6% to 63% for IDA (Fig. 6B),
and 14.3% to 55.6% for ETO (Figs. 6D and 6E, bottom panel).
Discussion
Topo2a levels and tumor proliferation rates are considered,
among others, predictive factors for the effective implementation
of Top2 poisons in chemotherapy. In addition, several breast
cancers have shown TOP2A amplification and overexpression
[40]; which makes them particularly susceptible to Top2 poisons.
Top2 poisons are widely exploited in cancer treatment, with
therapy-related secondary tumors being a major unresolved
problem. In order to improve chemotherapy, it is necessary to
understand better how cells do respond to Top2-mediated
damage.
In this study, we pursued two major aims. First, to determine
the role of Top2a in the generation of DNA DSB by Top2 poisons
in normal human cells. Secondly, to analyze the DSB repair
pathways responsible for the restoration of the genome integrity
following the Top2-mediated DNA damage.
Top2 poisons stabilize the cleavable complexes irrespective of
Top2 isoform. However, it has been suggested that Top2b is
mainly implicated in the induction of DSB, while Top2a is
essential for citotoxicity [30]. Although the role of Top2b in the
generation of DSB was attributed to the preferential degradation
by the proteasome pathway of Top2b-DNA cleavable complexes,
recent evidence demonstrated that both isoforms are targets for
the proteasome and that alternative processing mechanisms may
also be involved [41]. We show here that Topo2a is actively
implicated in the induction of cH2AX and citotoxicity by Top2
poisons on normal human fibroblasts. In this regard, two recent
reports are in line with our results: (i) in vitro studies on mice
tumoral cell lines showed that Top2a knock down resulted into
diminished DNA damage signals and increased resistance to
doxorubicin [42]; and (ii) NK314, a novel Top2a-specific poison
was shown to induce DSB efficiently in human tumoral cells [43].
Our data indicate that DNA DSB induced by subtoxic
concentration of Top2 poisons may occur at any stage of the
cell cycle and are mostly reversible lesions. To investigate the
involvement of NHEJ in the repair of Top2-mediated damage, we
use different approaches. We show that DNA-PKcs is rapidly
activated in response to DNA damage induced by Top2 poisons.
In addition, chemical inhibition of DNA-PKcs results into an
extensive accumulation of DSB in human cells. Furthermore,
Ku80- and DNA-PKcs-deficient Chinese hamster cell lines display
a hypersensitive phenotype, as assessed by clonogenic survival. In
close agreement with our data, it has been reported that the DNA-
PKcs deficient V3-3 Chinese hamster cell line was hypersensitive
to m-AMSA [44].
On the other hand, a previous study on chicken DT40 cell lines
suggested a major role for a DNA-PKcs-independent NHEJ
pathway in the repair of ETO-induced damage [45]. This
pathway is well represented in V(D)J recombination, where the
induced by ETO and IDA during the cell cycle (left panels) and the median intensity of fluorescence (IF) per cell cycle phase (right panel). (F) Flow
cytometry assessment of apoptotic cell death induced by ETO (10 mg/ml) or IDA (0.01 mg/ml) at 24, 48 and 72 h post-treatment.
doi:10.1371/journal.pone.0012541.g002
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PLoS ONE | www.plosone.org 5 September 2010 | Volume 5 | Issue 9 | e12541Figure 3. NHEJ is required for the repair of Top2 poisons-mediated DNA DSB. (A) Immunostaining analysis of activated DNA-PKcs in
human fibroblasts following the treatment with IDA (0.01 mg/ml) or ETO (10 mg/ml). Representative images are shown in the right panel. (B) Kinetics
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absence of DNA-PKcs, while coding joints which requires
nucleolytic end processing steps cannot [46,47]. Thus, it is
assumed the requirement of DNA-PKcs in NHEJ relies on the
DNA ends configuration. Our data demonstrate that in mamma-
lian cells DNA-PKcs-dependent NHEJ is strongly activated and
responsible for the repair of an important fraction of the DNA
DSB induced by Top2 poisons. However, we cannot rule out any
contribution of a DNA-PKcs-independent NHEJ mechanism.
Although most of the randomly occurring DSB generate
incompatible DNA termini, the exact nature of the DNA ends
resulting from Top2-mediated damage is not well understood. In
this regard, the observed activation of DNA-PKcs may also reflect
that incompatible DNA ends are generated.
To determine whether the conservative HR is also implicated in
the repair of Top2-mediated damage, we analyzed several end
points. In human fibroblasts Rad51 protein levels, Rad51 nuclear
foci and SCE are substantially increased following Top2-mediated
DSB. Similarly, an increased expression of Rad51 protein in
response to ETO was recently reported in colorectal adenocar-
cinoma cell lines [48]. Furthermore, BRCA2- and Rad51C-
mutant Chinese hamster cells show hypersensitivity to the Top2
poisons. In agreement with our findings, it was reported an
increased sensitivity to Top2 poisons of XRCC3-deficient Chinese
hamster cells [44], BRCA1- and BRCA2-mutant human tumoral
cells [49], and a middle sensitivity of rad54
2/2 and rad52
2/2
chicken DT40 cell lines [32,50].
Since NHEJ and HR may operate differently throughout the
cell cycle, we analyzed pS2056DNA-PKcs and Rad51 foci
formation on human fibroblasts subjected to cell cycle synchro-
nization. Our data show that DNA-PKcs-dependent NHEJ is
activated by Top2-mediated damage in all cell cycle phases, while
Rad51-dependent HR is induced in S and late S/G2 phases. The
spontaneous autophosphorylation of DNA-PKcs on S phase cells
was previously reported [22] and is believed to result from
physiologically relevant amounts of replication-associated DNA
DSB.
These results are consistent with the NHEJ and HR activities
reported on mammalian cells after ionizing radiation induced
damage [51] and I-SceI endonuclease-mediated DSB on chromo-
somally-integrated reporter systems [52].
Due to the middle sensitivity to ETO displayed by ku70
2/2
rad54
2/2 double mutants compared with the ku70
2/2 simple
mutant DT40 cells, Adachi et al. [32] proposed that HR-mediated
DSB repair may be a cytotoxic repair pathway for Top2-mediated
DNA damage. This was suggested assuming that Top2 poisons
induce an irreversible type of DNA damage, especially at high
doses, which could be a substrate for HR. Previous studies have
demonstrated that following genotoxic stress, micronuclei and
apoptotic cells containing Rad51 and RPA residual foci are
induced [37,38]. Therefore, we evaluated whether NHEJ- or HR-
mediated residual repair events result from persistent DNA
damage induced by Top2 poisons. The levels of micronuclei and
apoptotic cells containing pS2056DNA-PKcs remaining foci rise
with the increasing doses of the drugs. However, Rad51-mediated
residual repair events remain at similar low levels. Taking into
account the strength of the HR repair response, it is unlikely the
low level of cells showing HR-mediated residual foci may support
a cytotoxic effect of HR. On the other hand, the increased levels of
pS2056DNA-PKcs remaining foci on persistently DNA damaged
cells may represent a constant effort of the cell to restore
unrepaired DNA fragments, which could lead to mutations. It is
noteworthy that non-homologous-mediated end joining of DNA
DSB was proposed to reverse apoptosis, albeit at low frequency,
leading to the development of chromosomal translocations,
particularly those linked to t-AML [53,54].
Overall, our data support an important role of Top2a for the
induction of DNA DSB and cytotoxicity by Top2 poisons in
normal human cells. Moreover, both NHEJ and HR repair
activities are required to restore the genome integrity after Top2-
mediated DNA damage with cell cycle phase specificity. Finally,
the finding of activated DNA-PKcs residual foci on persistently
DNA damaged cells opens important questions about how long
the NHEJ components may continue operating to reverse the
DNA damage-induced apoptotic cell death and how the proper
degradation of NHEJ factors is controlled under this scenario.
Future studies should shed light on these issues and determine the
relevance of these mechanisms in the development of cancer.
Materials and Methods
Reagents, Cell cultures and treatments
IDA (CAS no. 58957-92-9; Pharmacia y Upjohn), bromode-
oxyuridine (BrdU; CAS no. 59-14-3; Sigma) and vanillin (VN;
CAS no. 121-33-5; Sigma) were dissolved in bidistilled water.
ETO (CAS no. 33419-42-0; Sigma) and wortmannin (WTM;
CAS no. 19545-26-7; Sigma) were dissolved in DMSO.
The human foreskin fibroblast cell line PTP, kindly provided by
Dr MI Tous (Servicio de Cultivo de Tejidos, Depto Virologı ´a,
ANLIS ‘‘CG Malbra ´n’’, Buenos Aires, Argentina), was grown in
Minimum Essential Medium supplemented with 10% FBS and
2 mM L-glutamine. Mutant hamster cell lines deficient in NHEJ
(XR-C1, XR-V15B) and HR (CL-V4B, V-C8) with their parental
cell lines (CHO9, V79B and V79) were used. CHO9, XR-C1 and
XR-V15B were grown in F-12 medium supplemented with 10%
FBS and 2 mM L-glutamine. V79, V79B, CL-V4B and V-C8
were cultured in Mc Coy’s 5A medium (without hypoxanthine and
thymidine) supplemented with 10% FBS. The hamster cell lines
were generously kindly provided by Prof Dr MZ Zdzienicka and
Dr W Wiegant (Leiden University, Leiden, The Netherlands). All
the cell cultures were incubated at 37uC under a 5% CO2
humidified atmosphere.
Human fibroblasts were treated with 0.01 mg/ml IDA or
10 mg/ml ETO for 2 h, unless otherwise specified. Chinese
hamster cell lines were treated for 20 h with different doses of
IDA or ETO, as specified in the figures.
Transfections and Top2a depletion
Exponentially growing human fibroblasts were transfected with
1 mM of morpholino antisense oligonucleotide targeting top2a
mRNAs (MO-Top2a; 59-TTTACAGGCTGCAATGGTGA-
CACTT-39; Gene Tools) or a standard control (MO-SC; 59-
of DSB repair in human fibroblasts pre-treated with VN (300 mM) or WTM (10 mM) and treated with IDA. (C) Graphical representation of the relative tail
moment (RTM) of (B) respect to IDA alone (Fig. 2A). Dotted line represents the tail moment shown by IDA alone as percentage. (D) Kinetics of DSB
repair in human fibroblasts pre-treated with VN (300 mM) or WTM (10 mM) and treated with ETO. (E) RTM of (D) respect to ETO alone (Fig. 2B). Dotted
line represents the tail moment shown by ETO alone as percentage. Capped lines (A–E) represent the extension of the treatments. Clonogenic
survival to IDA (F) or ETO (G) of the wild-type Chinese hamster cell lines CHO9 and V79B, and their NHEJ-mutant counterparts XR-C1 (DNA-PKcs
defective) and XR-V15B (Ku80 defective).
doi:10.1371/journal.pone.0012541.g003
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PLoS ONE | www.plosone.org 7 September 2010 | Volume 5 | Issue 9 | e12541Figure 4. HR is activated in response to DNA DSB induced by Top2 poisons. Rad51 foci are induced in human fibroblasts following treatment
with (A) IDA (0.01 mg/ml) or (B) ETO (10 mg/ml). The Rad51 protein levels also increase in response to (C) IDA or (D) ETO. Representative photographs of
western blot analysis are shown inside of figures C and D. Data were normalized respect to actin content. Capped lines (A–D) represent the time
extension of the treatment. (E) Frequency of sister chromatid exchanges (SCE) in human fibroblasts. (F–G) Clonogenic survival of the wild-type Chinese
hamster cell lines V79 and V79B, andtheir HR-mutant counterparts V-C8 (BRCA2 defective) and CL-V4B (Rad51C defective), following the treatment with
IDA or ETO. *p#0.0055 (vs. control); **p#0.028 (vs. control). Statistical comparisons were performed by the Student t-test.
doi:10.1371/journal.pone.0012541.g004
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PLoS ONE | www.plosone.org 8 September 2010 | Volume 5 | Issue 9 | e12541Figure 5. NHEJ and HR are differently required for the repair of Top2-mediated DNA damage in fibroblast cells. (A) Scheme of the
synchronization procedure for the analysis of Rad51 and activated DNA-PKcs foci in response to both IDA and ETO treatments. (i) Fibroblasts seeded
at ,90% of confluence were subjected to serum starvation during 48 h to obtain a cell population in G0/G1. The media was changed for complete
media and the cells were treated with 0.01 mg/ml IDA or 10 mg/ml ETO. Samples were fixed and processed for immunostaining as described in the
matherials and methods section. (ii) Fibroblasts at 50% of confluence were treated with 2 mM thymidine during 26 h to enrich the cell population in
the G1/S border. After washing, complete media containing BrdU (150 mM) and IDA or ETO was added for 1 h. After immunostaining, the scoring was
performed on those BrdU+ nuclei. (iii) Fibroblasts at 50% confluence were treated with 2 mM thymidine for 26 h. The cells were then rinsed and
cultured on fresh complete media for 5 h. After this recovery period, BrdU (150 mM) was added for 1 h and removed by washing with complete
media. Finally the cells were incubated with IDA or ETO for 2 h in complete media. Following immunostaining, late S/G2 nuclei were recognized by
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6 mM of Endo-Porter reagent (Gene Tools) in complete medium,
as specified by manufacturers. The efficiency of Top2a knock-
down was analyzed by immunofluorescence and western blot at
different time points.
Cell death analysis
For the assessment of cell death, three methodologies were used:
(i) Trypan Blue exclusion assay. After 48 h of transfection, human
fibroblasts growing on 48-well plates were treated for 2 h
with different doses of IDA or ETO and analyzed 36 h later
by adding 100 ml of 1% trypan blue solution into each well
containing 100 ml of complete medium. The percentage of
cell death was determined, under inverted microscope, in
300 cells from at least 8 different fields in 3 independent
experiments.
(ii) MTT assay. Human fibroblasts (2.5610
3) were cultured in
96-well plates, transfected with MO-Top2a and grown for
48 h. Then the cells were treated with the DSB inducer
drugs for 2 h and grown for other additional 36 h. The
MTT reagent [3-(4,5-dimethylthiazol- 2-yl)-2,5-diphenylte-
trazolium bromide; Sigma] was added for colorimetric
reaction up to a final concentration of 1 mg/ml. After 2 h
incubation at 37uC, cell lysis and MTT solubilization with
DMSO, samples were assayed in an ELISA reader at
570 nm. The MTT specific activity was determined and
expressed as the percentage of control from 3-5 independent
experiments.
(iii) Annexin V. For flow cytometry analysis of apoptosis, the
Annexin V-FITC Apoptosis Detection Kit (Calbiochem)
was used according to manufacturer’s instructions.
Neutral Comet assay
The human fibroblasts were mock or pretreated with WTM
(10 mM) or VN (300 mM) for 0.5 h before the exposure to IDA or
ETO and harvested after different periods of time. WTM and VN
were present in the media during all the culture time. We
performed the neutral single cell gel electrophoresis as described
by Angelis et al. [55] with slight modifications. Briefly, cell
suspensions were embedded in agarose and deposited in
microscope slides. The slides were incubated 2 h at 4uC in lysis
solution (2.5 M NaCl, 100 mM EDTA, 10 mM Tris, pH 10, 10%
DMSO, 1% Triton X-100) followed by 3 washes in neutralizing
buffer (0.4 M Tris-HCl, pH 7.5). Electrophoresis was carried out
for 20 min at 20 V in 0.5% TBE buffer (pH 8). Slides were then
stained with a 20 mg/ml ethidium bromide solution. Images from
50 nucleoids/sample/time-point were scored in 3 independent
experiments. The analysis of the tail moment (TM) was performed
with the CASP software.
Immunofluorescence
Human fibroblasts were grown in coverslips, fixed with 2%
paraformaldehyde and permeabilized with 0.25% Triton X-100
at room temperature. After blocking (3% BSA, 0.25% Triton X-
100 in PBS) for 1 h, cells were incubated for 2 h with mouse anti
Top2a (1:300; Chemicon; clone KiS1), mouse anti cH2AX
(1:500; Upstate; clone JBW301), rabbit anti Rad51 (1:250; Santa
Cruz) or rabbit anti pS2056DNA-PKcs (1:400; a generous gift
from Dr. BP Chen, University of Texas Southwestern Medical
Center, Dallas, USA). Appropriated secondary fluorescein
isothiocyanate (FITC) or Texas red-conjugated anti-rabbit
(1:250, Vector Laboratories) or anti-mouse (1:250, Vector
Laboratories) antibodies were used. DNA was counterstained
with 4,6-diamidino-2-phenylindole (DAPI; Vector Laboratories)
containing mounting medium.
Cell synchronization and immunolabelling
Human fibroblasts were synchronized in the different cell cycle
stages and treated with IDA or ETO as depicted in Figure 5A.
Cultures were fixed and permeabilized with 2% paraformalde-
hyde/0.5% Tween 20 in PBS for 20 min. Samples (S- and G2-
synchronized cells) were treated with 2N HCl for 30 min and then
neutralized with 0.1 M Borax buffer (sodium tetraborate, pH 8.5).
Immunofluorescence was performed as described previously. To
detect S- and G2-phase nuclei a monoclonal anti BrdU antibody
(1:200; Invitrogen) was used. One hundred nuclei were scored for
the presence of Rad51 or pS2056DNA-PKcs foci. Three
independent experiments were carried out for each treatment.
Flow cytometry
For flow cytometry analysis of cH2AX, cellular suspensions
were fixed with paraformaldehyde 1% in PBS and permeabilized
in 0.25% Triton X-100 in PBS, and then processed for
immunolabelling as previously described. After incubation with
the secondary antibody, samples were treated with 200 mg/ml
RNAse A and 20 mg/ml propidium iodide (PI) in PBS for 0.5 h at
37uC. Thirty-thousand cells per sample were evaluated and the
median cH2AX intensity of fluorescence per cell cycle phase was
calculated as described by Huang et al. [56].
Western blot
Whole cell extracts were prepared in RIPA buffer (50 mM
Tris-HCl pH 7, 150 mM NaCl, 1% NP-40, 0.5% sodium
deoxycolate and 0.1% SDS) containing a cocktail of protease
inhibitors and the protein concentrations were determined by the
Bradford method [57]. Fifty mg of total proteins were separated
on 8% SDS-PAGE and transferred onto PVDF membranes.
After blocking overnight in 0.2%Tween20/PBS containing 5%
non-fat dry milk, membranes were incubated for 2 h with mouse
anti Top2a antibody (1:500), mouse anti Top2b (1:500; Santa
Cruz), goat anti Tdp1 (1:400; Santa Cruz), rabbit anti Rad51
(1:1000) or mouse anti actin (loading control, 1:1000, Calbio-
chem) in blocking buffer. Appropriated HRP-conjugated anti
mouse, anti rabbit or anti goat antibodies (1:10000) and the ECL
kit (Amersham) were used for protein detection. Following
autoradiography, the bands were analyzed with the Gel Pro
analyzer software (Media Cybernetics).
Sister chromatid exchanges
Human fibroblasts were treated for 2 h with 0.01 mg/ml IDA or
10 mg/ml ETO and then, incubated in the presence of 10 mg/ml
BrdU for two complete rounds of replication (50 h). The average
frequency of SCE was determined from the analysis of 30
metaphases during the second cycle of division in three
independent experiments.
showing a complete labelling pattern of BrdU. (B) Analysis of activated DNA-PKcs in response to IDA or ETO at different phases of the cell cycle. (C)
Rad51 foci formation following IDA or ETO treatments at different stages of the cell cycle. *p#0.009 (vs. respective control); **p#0.03 (vs. respective
control). Statistical comparisons were performed by the Student t-test.
doi:10.1371/journal.pone.0012541.g005
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PLoS ONE | www.plosone.org 10 September 2010 | Volume 5 | Issue 9 | e12541Figure 6. Residual repair events are associated to persistently DNA damaged cells by Top2 poisons. Human fibroblasts treated with
increasing doses of IDA (A) or ETO (C) showing Rad51 residual repair events on micronuclei and apoptotic cells. Active DNA-PKcs remaining foci are
found in irreversibly DNA damaged cells following the treatments with IDA (B) and ETO (D) at different doses. (E) Representative images of
micronuclei (top panel) and apoptotic cells (bottom panel) containing activated DNA-PKcs foci following treatment with ETO.
doi:10.1371/journal.pone.0012541.g006
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Chinese hamster cells were plated at low density (300–1000
cells/dish), allowed to attach for 4 h, and treated with different
concentrations of IDA or ETO for 20 h. The cells were then
washed with PBS and cultured in fresh medium for 7–10 days.
After this growth period, the cells were rinsed with PBS, fixed with
methanol, and stained with crystal violet. Only colonies containing
more than 50 cells were scored. Survival fraction was calculated as
the ratio of colonies in drug-treated cultures compared with
control cultures and expressed in percentages. Three independent
experiments were carried out for each end point.
Rad51 and pS2056DNA-PKcs foci detection on
micronucleated and apoptotic cells
Human fibroblasts growing on coverslips were treated with
increased concentrations of IDA or ETO for 2 h. The cells were
washed and cultured in complete media for other additional 36 h.
To detect apoptotic cells we incubated the preparations with
FITC-annexin V, rinsed in washing buffer (10 mM HEPES/
NaOH, pH 7.4; 140 mM NaCl; 5 mM CaCl2), and simulta-
neously fixed and permeabilized in 1% paraformaldehyde
containing 0.25% Triton X-100/PBS at room temperature for
20 min. Samples were then immunolabelled with anti Rad51 or
anti pS2056DNA-PKcs as previously described. The frequency of
micronucleated and apoptotic cells containing either Rad51 or
pS2056DNA-PKcs foci was determined by analyzing at least 1000
cells per sample.
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